SHANDAL EMANUEL: Open Payments
NPI 1699777524 · NASHVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,173 in 168 payments from 25 companies in 2025. Trend: 2023 $8,317 · 2024 $7,440 · 2025 $3,173
Food & beverage: $3,173
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $397 |
| Axsome Therapeutics, Inc. | 16 | $362 |
| PFIZER INC. | 20 | $297 |
| Novo Nordisk Inc | 14 | $246 |
| AstraZeneca Pharmaceuticals LP | 9 | $197 |
| Corcept Therapeutics | 10 | $193 |
| Corium, LLC | 8 | $168 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $156 |
| Otsuka America Pharmaceutical, Inc. | 9 | $156 |
| Amgen Inc. | 11 | $140 |
Products named: Auvelity, Korlym, Azstarys, CAPLYTA, REXULTI, UBRELVY, NURTEC ODT, TRELEGY ELLIPTA.
Industry payments across NC — which companies pay providers there.
